Mirion Technologies, Inc. (MIR) stock analysis
Industrials · Specialty Industrial Machinery
From the 10-K filed 2026-02-19
Business type: Treadmill
How it makes money
It generates over 80% of nuclear power revenue from replacement and services within an installed base spanning 98% of global nuclear plants.
Revenue is anchored by the 40 to 100 year operating life cycle of nuclear power plants, where it provides essential reactor instrumentation and radiation monitoring.
The Medical segment complements this through dosimetry services, badging over 1 million healthcare workers, and providing quality assurance hardware to 80% of cancer centers worldwide.
What protects it: the moat
High switching costs and strict regulatory qualifications for radiation safety systems protect long-term relationships with utility operators and 23 NATO militaries.
The company relies on a 60-year history of technical excellence and 183 issued patents to meet demanding specifications for harsh nuclear environments. Customers prioritize proven reliability and supplier longevity, as equipment failures could lead to catastrophic environmental contamination or incorrect medical treatments.
What could damage it
A single nuclear incident or a shift in public opinion could trigger stricter regulations and permanently impair demand for its monitoring products.
Its expansion strategy heavily depends on the commercialization of Small Modular Reactors. This emerging market faces significant obstacles, including regulatory licensing delays and the potential failure of new entrants to secure the massive investments required for nuclear technologies.
About Mirion Technologies, Inc.
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company also offers include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.